AZN Jul 2024 80.000 call
| Previous close | 2.3700 |
| Open | 2.6000 |
| Bid | 2.6100 |
| Ask | 2.6600 |
| Strike | 80.00 |
| Expiry date | 2024-07-19 |
| Day's range | 2.2600 - 2.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.06k |
Fool.co.uk2 superb FTSE 100 stocks I’d buy for a SIPP and hold for a decade
This Fool highlights a pair of excellent blue-chip stocks that he'd buy today and tuck away in a SIPP portfolio for the long run. The post 2 superb FTSE 100 stocks I’d buy for a SIPP and hold for a decade appeared first on The Motley Fool UK.
PR NewswireAbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced preliminary safety and efficacy results from its first time in human investigator-initiated trial (IIT) of C-CAR031 in connection with the Company's oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The presentation shared data indicati
ZacksAstrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Astrazeneca (AZN) closed at $78.99, marking a +1.24% move from the previous day.
